Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT03384563
PHASE4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
Sponsor: Baylor College of Medicine
View on ClinicalTrials.gov
Summary
The purpose of this protocol is to determine the effect of two clinically applicable Dexmedetomidine dosages (0.5mcg/kg and 1mcg/kg) on the minimum alveolar concentration (MAC) of Sevoflurane in children between the age ranges of: 1-6 months; 6-12 months of age and 12 months-36 months years of age.
Key Details
Gender
All
Age Range
1 Month - 36 Months
Study Type
INTERVENTIONAL
Enrollment
180
Start Date
2018-02-18
Completion Date
2025-12-31
Last Updated
2025-09-22
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Dexmedetomidine
Dexmedetomidine 9 arms
Locations (1)
Texas Children's Hospital
Houston, Texas, United States